These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Evaluation of calcineurin's role in the immunosuppressive activity of FK 506, related macrolactams, and cyclosporine. Lane BC; Miller LN; Kawai M; Or YS; Wiedeman P; Holzman TF; Luly JR Transplant Proc; 1993 Feb; 25(1 Pt 1):644-6. PubMed ID: 7679829 [No Abstract] [Full Text] [Related]
23. Molecular mechanisms of immunosuppressive agents. Borel JF; Baumann G Bull Mem Acad R Med Belg; 1994; 149(1-2):97-101; discussion 101-3. PubMed ID: 7531051 [TBL] [Abstract][Full Text] [Related]
24. The mechanism of action of FK 506. Kay JE; Moore AL; Doe SE; Benzie CR; Schönbrunner R; Schmid FX; Halestrap AP Transplant Proc; 1990 Feb; 22(1):96-9. PubMed ID: 1689914 [No Abstract] [Full Text] [Related]
25. Prolyl isomerase: enzymatic catalysis of slow protein-folding reactions. Schmid FX Annu Rev Biophys Biomol Struct; 1993; 22():123-42. PubMed ID: 7688608 [No Abstract] [Full Text] [Related]
27. Immunophilins, ligands, and the control of signal transduction. Schreiber SL; Crabtree GR Harvey Lect; 1995-1996; 91():99-114. PubMed ID: 9127988 [No Abstract] [Full Text] [Related]
28. Study of the immunosuppressive properties of cyclosporine analogues. Reem GH; el Rouby S; Shi Y Ann N Y Acad Sci; 1993 Jun; 685():336-8. PubMed ID: 8363236 [No Abstract] [Full Text] [Related]
29. [Protein folding and its catalysts in the cell]. Takahashi N; Hayano T; Suzuki M Tanpakushitsu Kakusan Koso; 1991 Sep; 36(11):1821-34. PubMed ID: 1956998 [No Abstract] [Full Text] [Related]
30. The mechanisms of action of cyclosporin A : implications for its side effects. Takahashi N J Toxicol Sci; 1995 Sep; 20(4):480-2. PubMed ID: 8531247 [No Abstract] [Full Text] [Related]
31. Prolyl isomerases: role in protein folding. Schmid FX; Mayr LM; Mücke M; Schönbrunner ER Adv Protein Chem; 1993; 44():25-66. PubMed ID: 8317297 [No Abstract] [Full Text] [Related]
32. Structural and functional features of the peptidyl prolyl cis-trans isomerase, cyclophilin. Harding MW Pharmacotherapy; 1991; 11(6):142S-148S. PubMed ID: 1771139 [No Abstract] [Full Text] [Related]
33. Biosynthesis and mechanism of action of cyclosporins. Lawen A Prog Med Chem; 1996; 33():53-97. PubMed ID: 8776941 [No Abstract] [Full Text] [Related]
34. Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A. Flanagan WM; Corthésy B; Bram RJ; Crabtree GR Nature; 1991 Aug; 352(6338):803-7. PubMed ID: 1715516 [TBL] [Abstract][Full Text] [Related]
35. Leukocyte chemotactic activity of FKBP and inhibition by FK506. Leiva MC; Lyttle CR Biochem Biophys Res Commun; 1992 Jul; 186(2):1178-83. PubMed ID: 1379802 [TBL] [Abstract][Full Text] [Related]
36. Yeast cyclophilin-related gene encodes a nonessential second peptidyl-prolyl cis-trans isomerase associated with the secretory pathway. Tanida I; Yanagida M; Maki N; Yagi S; Namiyama F; Kobayashi T; Hayano T; Takahashi N; Suzuki M Transplant Proc; 1991 Dec; 23(6):2856-61. PubMed ID: 1721297 [No Abstract] [Full Text] [Related]
37. Signal transduction. Immunosuppressants at work. DeFranco AL Nature; 1991 Aug; 352(6338):754-5. PubMed ID: 1715515 [No Abstract] [Full Text] [Related]
38. Biology of cyclosporin A and FK506. Bierer BE Prog Clin Biol Res; 1994; 390():203-23. PubMed ID: 7536944 [No Abstract] [Full Text] [Related]
39. The human erythrocyte membrane contains a novel 12-kDa inositolphosphate-binding protein that is an immunophilin. Cunningham EB Biochem Biophys Res Commun; 1995 Oct; 215(1):212-8. PubMed ID: 7575593 [TBL] [Abstract][Full Text] [Related]